Lv1
85 积分 2020-07-09 加入
Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
2年前
已完结
Adjuvant abemaciclib for high-risk breast cancer: the story continues
2年前
已完结
Management of Pediatric Generalized Pustular Psoriasis Using Biologics: An Evidence-Based Review
3年前
已完结
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies
3年前
已完结
Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study
3年前
已完结
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60)
3年前
已完结
In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy
3年前
已完结
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials
3年前
已完结
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial
3年前
已完结
皖公网安备34019202002308
